Analyst Reco.

06-11 SB1 maintains buy rating on Novo Nordisk following industry conference FW
06-09 NOVO NORDISK : Deutsche Bank reiterates its Neutral rating ZD
06-09 NOVO NORDISK : JP Morgan sticks Neutral ZD
06-08 NOVO NORDISK : JP Morgan remains Neutral ZD
06-04 NOVO NORDISK : Goldman Sachs gives a Neutral rating ZD
06-03 Goldman Sachs raises Novo Nordisk price target to DKK 305 (263), maintains Neutral rating - BN FW
05-29 NOVO NORDISK : Jefferies remains Neutral ZD
05-29 Jefferies Examines GLP-1 Compounding, Maintains Hold Rating on Novo Nordisk Zonebourse
05-28 NOVO NORDISK : Deutsche Bank reiterates its Neutral rating ZD
05-21 Bernstein Updates Novo Nordisk Price Target, Estimates After Wegovy Pill Launch Outperforms MT
05-21 Bernstein raises price target for Novo Nordisk to DKK 200 (175), reiterates underperform - BN FW
05-20 NOVO NORDISK : Deutsche Bank sticks Neutral ZD
05-20 Intron: Novo Nordisk sales could decline in 2027 FW
05-19 NOVO NORDISK : Barclays reiterates its Neutral rating ZD
05-18 Novo Nordisk slides on signs of slowing sales momentum for Wegovy pill FW
05-13 NOVO NORDISK : Jefferies reaffirms its Neutral rating ZD
05-12 NOVO NORDISK : Bernstein keeps a Sell rating ZD
05-11 Citi raises Novo Nordisk price target following strong Wegovy pill launch FW
05-11 SB1: Market underestimates Novo Nordisk potential - raises price target FW
05-11 SB1 Markets raises Novo Nordisk price target to DKK 350 (280), reiterates Buy FW
05-11 Citigroup raises Novo Nordisk price target to DKK 290 (275), reiterates Neutral rating FW
05-08 NOVO NORDISK : Deutsche Bank gives a Neutral rating ZD
05-08 NOVO NORDISK : Gets a Neutral rating from JP Morgan ZD
05-08 NOVO NORDISK : UBS sticks Neutral ZD
05-08 NOVO NORDISK : Barclays sticks Neutral ZD
No results match your criteria
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!